ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN)
CUSIP: 74346M406
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 9,081,600
- Total 13F shares
- 9,993,894
- Share change
- +1,573,628
- Total reported value
- $4,247,586
- Price per share
- $0.42
- Number of holders
- 23
- Value change
- +$501,350
- Number of buys
- 12
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 74346M406?
CUSIP 74346M406 identifies PMN - ProMIS Neurosciences Inc. - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74346M406:
Top shareholders of PMN - ProMIS Neurosciences Inc. - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Shaf QIC LLC |
13D/G
3/4/5
|
10%+ Owner |
10%
|
10,534,639
|
$5,096,658 | $0 | 29 Jul 2025 | |
| Jeremy M. Sclar |
3/4/5
13D/G
|
10%+ Owner |
17%
from 13D/G
|
10,385,829
mixed-class rows
|
$5,072,406 | — | 25 Jul 2025 | |
| GREAT POINT PARTNERS LLC |
13D/G
13F
|
Company |
10%
|
5,972,369
|
$2,547,215 | +$1,125,043 | 30 Sep 2025 | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,849,992
mixed-class rows
|
$2,337,589 | — | 25 Jul 2025 | |
| 19 Promis Title |
3/4/5
|
Other* |
—
mixed-class rows
|
4,010,077
mixed-class rows
|
$1,178,067 | — | 25 Jul 2025 | |
| Michael S. Gordon |
3/4/5
|
Other* |
—
mixed-class rows
|
4,010,077
mixed-class rows
|
$1,178,067 | — | 25 Jul 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
24%
|
2,137,896
|
$1,034,314 | — | 30 Jun 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
21%
|
1,899,297
|
$918,880 | — | 30 Jun 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
15%
|
1,334,428
|
$645,596 | — | 30 Jun 2025 | |
| Madge K. Shafmaster |
3/4/5
|
Director |
—
mixed-class rows
|
228,333
mixed-class rows
|
$270,916 | — | 12 Jun 2025 | |
| Gail M. Farfel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
108,384
mixed-class rows
|
$256,091 | — | 23 Aug 2023 | |
| Allostery Investments LP |
13F
|
Company |
1.7%
|
155,720
|
$76,303 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.7%
|
63,429
|
$31,080 | — | 30 Jun 2025 | |
| Graypoint LLC |
13F
|
Company |
0.58%
|
52,833
|
$25,561 | — | 30 Jun 2025 | |
| Kingsview Wealth Management, LLC |
13F
|
Company |
0.34%
|
31,062
|
$15,028 | — | 30 Jun 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.33%
|
30,366
|
$14,879 | — | 30 Jun 2025 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.31%
|
28,583
|
$13,828 | — | 30 Jun 2025 | |
| HOWARD FINANCIAL SERVICES, LTD. |
13F
|
Company |
0.29%
|
26,042
|
$12,599 | — | 30 Jun 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.29%
|
26,042
|
$12,599 | — | 30 Jun 2025 | |
| Gavin T. Malenfant |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
17,820
mixed-class rows
|
$12,342 | — | 26 Oct 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.13%
|
11,447
|
$6,000 | — | 30 Jun 2025 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.13%
|
12,122
|
$5,857 | — | 30 Jun 2025 | |
| Claret Asset Management Corp |
13F
|
Company |
0.12%
|
11,330
|
$5,000 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
5,487
|
$3,000 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,666
|
$805 | — | 30 Jun 2025 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
133
|
$64 | — | 30 Jun 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
88
|
$42 | — | 30 Jun 2025 | |
| Larry Douglas Altstiel |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
165,000
|
— | — | 22 Sep 2025 | |
| Josh Mandel-Brehm |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Jun 2025 | |
| William W. Wyman |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Jun 2025 | |
| Daniel E. Geffken |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
2,500
|
— | — | 26 Oct 2023 |
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN) as of Q3 2025
As of 30 Sep 2025,
ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,993,894 shares.
The largest 10 holders included
Ally Bridge Group (NY) LLC, ARMISTICE CAPITAL, LLC, SPHERA FUNDS MANAGEMENT LTD., CITADEL ADVISORS LLC, HRT FINANCIAL LP, XTX Topco Ltd, BANK OF MONTREAL /CAN/, Fiduciary Trust Co, IEQ CAPITAL, LLC, and HOWARD FINANCIAL SERVICES, LTD..
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
19
Q3 2025 holders
23
Holder diff
4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.